Gregory A. Abel

205 papers receiving 4.7k citations

Hit Papers

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era 2013 · 609 citations
6090+4+8Years since publication200400600

Peers

Gregory A. Abel
Comparison fields: 5 of 140
  • Geriatrics and Gerontology 439
  • Hematology 982
  • Pathology and Forensic Medicine 1.2k
  • Genetics 672
  • Oncology 1.7k
Replace Grace L. Smith with:
Grace L. Smith United States
Eva Culakova United States
Fabio Efficace Italy
Floortje Mols Netherlands
Kathleen J. Yost United States
K.C.A. Sneeuw Netherlands
Annelies Boonen Netherlands
Chris Hyde United Kingdom
S. Kaasa Norway
M. Klee Denmark
Gregory A. Abel relative to Grace L. Smith United States Grace L. Smith's profile →
Citations per field
00.5×3.1×
Grace L. Smith · 1×
Citations per year

Countries citing papers authored by Gregory A. Abel

Since Specialization
Citations

This map shows the geographic impact of Gregory A. Abel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory A. Abel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory A. Abel more than expected).

Fields of papers citing papers by Gregory A. Abel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory A. Abel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory A. Abel. The network helps show where Gregory A. Abel may publish in the future.

Co-authors

The 25 scholars most cited alongside Gregory A. Abel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gregory A. Abel Line = papers co-authored together Gregory A. Abel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 221 papers — load more, or switch the sort, to bring in the rest.

#Work
1
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Hit paper breakdown →
2013609
2
Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
Hit paper breakdown →
2013389
3 2001303
4 2019135
5 2017134
6 2014133
7 2020116
8 2015105
9 201695
10 201285
11 201376
12 201374
13 201868
14 201166
15 200864
16 201263
17 200960
18 201659
19 201759
20 201454

About Gregory A. Abel

Gregory A. Abel is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Hematology, Economics and Econometrics and Pediatrics, Perinatology and Child Health, having authored 221 papers that have together received 4.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (46 papers), Palliative Care and End-of-Life Issues (43 papers), Health Systems, Economic Evaluations, Quality of Life (29 papers), Cancer survivorship and care (29 papers), Childhood Cancer Survivors' Quality of Life (29 papers), Frailty in Older Adults (26 papers), Lymphoma Diagnosis and Treatment (24 papers) and Economic and Financial Impacts of Cancer (23 papers). The work is most often cited by research in Geriatrics and Gerontology (439 citations), Hematology (982 citations), Pathology and Forensic Medicine (1.2k citations), Genetics (672 citations) and Oncology (1.7k citations). Gregory A. Abel has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Oreofe O. Odejide, Ann S. LaCasce, Nancy L. Keating, Stacie B. Dusetzina, Aaron N. Winn, Haiden A. Huskamp, Heidi D. Klepin, Angel M. Cronin, Richard M. Stone and Jane A. Driver. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Blood Advances and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact